Magnetic resonance imaging is effective for evaluating the therapeutic effect of tolvaptan on total kidney volume in patients with autosomal dominant polycystic kidney disease

Table 1 Baseline clinical characteristics of patients before treatment

	Age (year)	Sex	Serum Cr (mg/dL)	eGFR (mL/min/1.73m²)	CKD stage	TKV(ml)	Cerebral aneurysm
Case1	37	Male	0.76	92.9	G1A1	788	(−)
Case2	51	Female	0.89	52.7	G3aA1	1070	(−)
Case3	55	Male	1.29	46.5	G3aA1	1756	(−)
Case4	38	Male	1.67	39.0	G3bA1	4060	(+)
Case5	54	Male	1.56	38.0	G3bA1	2165	(−)
Case6	52	Female	1.80	24.3	G4A2	1313	(−)

Cr, creatinine; eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease; TKV, total kidney volume

ISSN: 2059-1381